Navina raises $55-M in a Series C funding, bringing its total investment to $100 million. Led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors Vertex Ventures Israel, Grove Ventures, and ALIVE, the funding will support the company’s expansion into the U.S. healthcare market.
The funding arrives at a crucial time for the healthcare industry, which is facing complex data challenges, administrative inefficiencies, and a shift toward value-based care. Navina’s AI-powered copilot aims to tackle these issues by providing real-time, data-driven insights that enable clinicians to offer patients more proactive, efficient, and personalized care.
Founded in 2018 by CEO Ronen Lavi and CTO Shay Perera, who were part of the team behind the IDF’s Intelligence Corps AI lab, Navina addresses critical challenges in healthcare.
Fragmented patient data and time-consuming administrative tasks often hinder clinicians from delivering optimal care. Navina’s platform integrates effortlessly into existing clinical workflows, transforming complex health records into clear, actionable insights. Navina has become a key player in the changing healthcare landscape, with more than 10,000 healthcare professionals across 1,300 clinics using the platform.
“AI is rapidly transforming modern healthcare, and Navina stands at the forefront of that transformation—delivering real, measurable value to thousands of clinicians,” said Irit Kahan, Managing Director in Growth Equity at Goldman Sachs Alternatives. “Their deep integration into clinical workflows, unparalleled provider trust, and demonstrated ROI make them uniquely positioned to drive meaningful impact across the healthcare ecosystem.”
Navina’s approach has earned the confidence of leading healthcare organizations such as Agilon Health, InnovaCare Health, Millennium Physician Group, and Privia Health.
“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI,” said Ronen Lavi, Navina’s co-founder and CEO. “We’re thrilled to partner with a firm like Goldman Sachs as we enter this pivotal growth phase and expand our market reach.”
With the new funding, Navina plans to advance its proprietary AI technology, further automate clinical workflows, and broaden its scope from population health management to point-of-care interventions. The company aims to become the leading source of unified patient data, facilitating more efficient decision-making across the healthcare ecosystem, from payers to providers.
